151 related articles for article (PubMed ID: 24554540)
1. Sublingual vaccine with GroEL attenuates atherosclerosis.
Hagiwara M; Kurita-Ochiai T; Kobayashi R; Hashizume-Takizawa T; Yamazaki K; Yamamoto M
J Dent Res; 2014 Apr; 93(4):382-7. PubMed ID: 24554540
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunization with recombinant GroEL plus CpG-ODN inhibits Porphyromonas gingivalis-induced inflammation and alveolar bone loss.
Chang E; Kobayashi R; Hagiwara-Hamano M; Kurita-Ochiai T; Komiya M
Mol Oral Microbiol; 2022 Apr; 37(2):31-41. PubMed ID: 34921516
[TBL] [Abstract][Full Text] [Related]
3. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Infect Immun; 2008 Jul; 76(7):2958-65. PubMed ID: 18426881
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
[TBL] [Abstract][Full Text] [Related]
5. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
6. Porphyromonas gingivalis HSP60 peptides have distinct roles in the development of atherosclerosis.
Jeong E; Kim K; Kim JH; Cha GS; Kim SJ; Kang HS; Choi J
Mol Immunol; 2015 Feb; 63(2):489-96. PubMed ID: 25457882
[TBL] [Abstract][Full Text] [Related]
7. Anti-P. gingivalis response correlates with atherosclerosis.
Ford PJ; Gemmell E; Timms P; Chan A; Preston FM; Seymour GJ
J Dent Res; 2007 Jan; 86(1):35-40. PubMed ID: 17189460
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
[TBL] [Abstract][Full Text] [Related]
9. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model.
Herminajeng E; Sosroseno W; Bird PS; Seymour GJ
J Periodontol; 2001 Nov; 72(11):1527-34. PubMed ID: 11759864
[TBL] [Abstract][Full Text] [Related]
10. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: Preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides.
Grundtman C; Jakic B; Buszko M; Onestingel E; Almanzar G; Demetz E; Dietrich H; Cappellano G; Wick G
Atherosclerosis; 2015 Sep; 242(1):303-10. PubMed ID: 26233917
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles of lesional and splenic T cells in Porphyromonas gingivalis infection in a murine model.
Gemmell E; Winning TA; Bird PS; Seymour GJ
J Periodontol; 1998 Oct; 69(10):1131-8. PubMed ID: 9802713
[TBL] [Abstract][Full Text] [Related]
13. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
14. Pep19 drives epitope spreading in periodontitis and periodontitis-associated autoimmune diseases.
Kwon EY; Cha GS; Jeong E; Lee JY; Kim SJ; Surh CD; Choi J
J Periodontal Res; 2016 Jun; 51(3):381-94. PubMed ID: 26362417
[TBL] [Abstract][Full Text] [Related]
15. The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice.
Gemmell E; Winning TA; Grieco DA; Bird PS; Seymour GJ
J Periodontol; 2000 Jul; 71(7):1130-8. PubMed ID: 10960020
[TBL] [Abstract][Full Text] [Related]
16. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
[TBL] [Abstract][Full Text] [Related]
17. Identification of immunoreactive epitopes of the Porphyromonas gingivalis heat shock protein in periodontitis and atherosclerosis.
Choi J; Lee SY; Kim K; Choi BK
J Periodontal Res; 2011 Apr; 46(2):240-5. PubMed ID: 21241301
[TBL] [Abstract][Full Text] [Related]
18. Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice.
Zhang T; Kurita-Ochiai T; Hashizume T; Du Y; Oguchi S; Yamamoto M
FEMS Immunol Med Microbiol; 2010 Jul; 59(2):143-51. PubMed ID: 20482627
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with Porphyromonas gingivalis and atherosclerosis.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Immunopharmacol Immunotoxicol; 2009; 31(3):352-7. PubMed ID: 19555215
[TBL] [Abstract][Full Text] [Related]
20. Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity.
Zhang T; Hashizume T; Kurita-Ochiai T; Yamamoto M
Biochem Biophys Res Commun; 2009 Dec; 390(3):937-41. PubMed ID: 19852927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]